Literature DB >> 4708696

Contamination of commercially available intermediates of the glycolytic pathway.

H Niessner, E Beutler.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4708696     DOI: 10.1007/BF01926467

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  7 in total

1.  Influence of 2,3-diphosphoglycerate on phosphofructokinase of human erythrocytes?

Authors:  G E Staal; J F Koster
Journal:  FEBS Lett       Date:  1972-06-01       Impact factor: 4.124

2.  Reduced nicotinamide adenine dinucleotide-linked analysis of 2,3-diphosphoglyceric acid: spectrophotometric and fluorometric procedures.

Authors:  A S Keitt
Journal:  J Lab Clin Med       Date:  1971-03

3.  2,3-diphosphoglycerate affects enzymes of glucose metabolism in red blood cells.

Authors:  E Beutler
Journal:  Nat New Biol       Date:  1971-07-07

4.  Electrophoretic heterogeneity of mammalian galactose dehydrogenase.

Authors:  P Cuatrecasas; S Segal
Journal:  Science       Date:  1966-10-28       Impact factor: 47.728

5.  Galactose conversion to D-xylulose: an alternate route of galactose metabolism.

Authors:  P Cuatrecasas; S Segal
Journal:  Science       Date:  1966-07-29       Impact factor: 47.728

6.  Hexokinase isoenzymes in liver and adipose tissue of man and dog.

Authors:  J Brown; D M Miller; M T Holloway; G D Leve
Journal:  Science       Date:  1967-01-13       Impact factor: 47.728

7.  Hexokinase isoenzymes in human erythrocytes.

Authors:  J C Kaplan; E Beutler
Journal:  Science       Date:  1968-01-12       Impact factor: 47.728

  7 in total
  1 in total

1.  Studies of enzyme polymorphisms in the Kamuela population of Drosophila mercatorum. II. Evaluation of glycolytic intermediates.

Authors:  R L Clark; G J Brewer; C F Sing
Journal:  Biochem Genet       Date:  1982-12       Impact factor: 1.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.